The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta‐Analysis
L Tang, Y Wang, Y Chen, L Chen… - BioMed Research …, 2017 - Wiley Online Library
The serotonin receptor gene (5‐HT2A) has been reported to be a susceptible factor in
behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD) …
behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD) …
Role of 5HT2A and 5HT2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease
AL Pritchard, J Harris, CW Pritchard, J Coates… - Neurobiology of …, 2008 - Elsevier
OBJECTIVE: Alzheimer's disease (AD) patients suffer from behavioural and psychological
symptoms of dementia (BPSD). A genetic component to BPSD development in AD has been …
symptoms of dementia (BPSD). A genetic component to BPSD development in AD has been …
5‐HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease
Objective To investigate the association between 5‐HT2A receptor polymorphism and
neuropsychiatric (NP) symptoms in Chinese elderly with Alzheimer's disease (AD). Methods …
neuropsychiatric (NP) symptoms in Chinese elderly with Alzheimer's disease (AD). Methods …
Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease
F Assal, M Alarcón, EC Solomon… - Archives of …, 2004 - jamanetwork.com
Background Serotonin has been linked to neuropsychiatric symptoms in Alzheimer disease,
mainly agitation/aggression, depression, and psychosis. Neuropsychiatric symptoms have …
mainly agitation/aggression, depression, and psychosis. Neuropsychiatric symptoms have …
Analysis of the 5HT‐2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease
D Craig, C Donnelly, D Hart, R Carson… - American Journal of …, 2007 - Wiley Online Library
Although the aetiology of psychotic symptoms in Alzheimer's disease (AD) is multi‐factorial,
alterations in serotonergic neurotransmission are often implicated. Polymorphisms of the …
alterations in serotonergic neurotransmission are often implicated. Polymorphisms of the …
[HTML][HTML] Serotonin receptor gene polymorphisms are associated with cerebrospinal fluid, genetic, and neuropsychological biomarkers of Alzheimer's disease
A decrease in serotonergic transmission throughout the brain is among the earliest
pathological changes in Alzheimer's disease (AD). Serotonergic receptors are also affected …
pathological changes in Alzheimer's disease (AD). Serotonergic receptors are also affected …
Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease
B Nacmias, A Tedde, P Forleo, S Piacentin… - Biological …, 2001 - Elsevier
Background: The aim of this study is to analyze the segregation of the 102T/C polymorphism
in the serotonin 2A receptor gene in patients affected by sporadic and familial Alzheimer's …
in the serotonin 2A receptor gene in patients affected by sporadic and familial Alzheimer's …
Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis
S Ramanathan, SJ Glatt - The American Journal of Geriatric Psychiatry, 2009 - Elsevier
Objective: The authors attempted to understand the role of two serotonin system genes,
HTR2A and SLC6A4, on psychosis associated with Alzheimer dementia (AD). Method …
HTR2A and SLC6A4, on psychosis associated with Alzheimer dementia (AD). Method …
Serotoninergic Polymorphisms (5-HTTLPR and 5-HT2A): Association Studies with Psychosis in Alzheimer Disease
A Rocchi, D Micheli, R Ceravolo, ML Manca… - Genetic …, 2003 - liebertpub.com
Patients with Alzheimer disease (AD) often exhibit psychotic symptoms associated with
cognitive impairment. A few association studies have been carried out to determine if the …
cognitive impairment. A few association studies have been carried out to determine if the …
Serotonin transporter and serotonin receptor 2A gene polymorphisms in Alzheimer's disease
Á Fehér, A Juhász, A László, M Pákáski, J Kálmán… - Neuroscience …, 2013 - Elsevier
Genetic variants of the serotonergic neurotransmitter system are potential contributing
factors in the pathological processes underlying Alzheimer's disease (AD). We examined …
factors in the pathological processes underlying Alzheimer's disease (AD). We examined …